Candel Therapeutics, Inc. — Institutional Ownership

Which tracked institutions hold CADL, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.

16
Funds holding
$24752385
Total value held
Buying
14 added/new · 2 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $15234307 3109042 +247353 +8.64%
2 State Street Corp $4010934 818558 +26340 +3.32%
3 Northern Trust Corp $1583455 323154 +27716 +9.38%
4 Goldman Sachs Group Inc $1114853 227521 +162436 +249.58%
5 Janus Henderson Group Plc $845272 171978 NEW BUY
6 Bank Of New York Mellon Corp $667701 136266 +41058 +43.12%
7 Wells Fargo & Company/Mn $417530 73899 +47588 +180.87%
8 Morgan Stanley $285323 58229 -75802 -56.56%
9 Bank Of America Corp /De/ $232270 47402 -3880 -7.57%
10 Raymond James Financial Inc $196000 40000 +7000 +21.21%
11 Invesco Ltd. $84971 15039 +3380 +28.99%
12 Barclays Plc $57325 11699 NEW BUY
13 Citigroup Inc $15108 2674 +963 +56.28%
14 Us Bancorp \De\ $3582 731 NEW BUY
15 Royal Bank Of Canada $3000 600 NEW BUY
16 Pnc Financial Services Group, Inc. $754 154 +149 +2980.00%

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.